RADANO, ILARIA
 Distribuzione geografica
Continente #
NA - Nord America 145
EU - Europa 98
AS - Asia 79
SA - Sud America 17
Totale 339
Nazione #
US - Stati Uniti d'America 145
RU - Federazione Russa 47
SG - Singapore 29
IT - Italia 28
HK - Hong Kong 18
BR - Brasile 17
CN - Cina 16
IE - Irlanda 9
TR - Turchia 7
DE - Germania 5
JP - Giappone 5
CZ - Repubblica Ceca 3
NL - Olanda 3
SE - Svezia 3
AE - Emirati Arabi Uniti 1
IN - India 1
IQ - Iraq 1
PS - Palestinian Territory 1
Totale 339
Città #
Chandler 26
Ashburn 18
Hong Kong 17
Singapore 17
Princeton 14
Los Angeles 13
Boardman 9
Dublin 9
Moscow 7
Salerno 7
Izmir 6
São Paulo 6
Beijing 5
Andover 4
Ann Arbor 4
Jacksonville 4
Tokyo 4
Wilmington 4
Brno 3
Rome 3
Washington 3
Florence 2
Messina 2
Palermo 2
Redwood City 2
Al Ain City 1
Amsterdam 1
Assis 1
Baghdad 1
Bareggio 1
Brasília 1
Cambridge 1
Campinas 1
Changsha 1
Chuzhou 1
Duque de Caxias 1
Esslingen am Neckar 1
Fortaleza 1
Hangzhou 1
Houston 1
Inhumas 1
Maricá 1
Munich 1
Nanchang 1
Norwalk 1
Osaka 1
Palmeiras de Goiás 1
Pune 1
Ramallah 1
Recife 1
Ribeirão Preto 1
Rio de Janeiro 1
Sarno 1
Shanghai 1
Siena 1
Uşak 1
Walnut 1
Woodbridge 1
Yiwu 1
Totale 225
Nome #
Beta-blockers are associated with better long-term survival in patients with Takotsubo syndrome 63
Transcatheter repair of functional mitral regurgitation in heart failure patients: A meta-analysis of 23 studies on mitraclip implantation 49
Safety and efficacy of non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation 49
Meta-Analysis Comparing Outcomes After Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents in Patients with Acute Coronary Syndromes 43
Long-term outcome in patients with Takotsubo syndrome presenting with severely reduced left ventricular ejection fraction 39
Epidemiology, Pathogenesis, and Clinical Course of Takotsubo Syndrome 25
[Cardiovascular management of patients with chronic myeloid leukemia treated with BCR-ABL tyrosine kinase inhibitors: it is time for a shared management] 24
A novel missense mutation for Fabry disease detected by echocardiographic screening in left ventricular hypertrophy patients 24
Importance of Echocardiography and Clinical "Red Flags" in Guiding Genetic Screening for Fabry Disease 19
Predictors of sacubitril/valsartan high dose tolerability in a real world population with HFrEF 17
[Diagnosis of cardiovascular involvement in Fabry disease] 12
Totale 364
Categoria #
all - tutte 2.306
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.306


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202012 0 0 0 0 0 0 0 0 0 0 10 2
2020/202110 1 0 0 0 2 0 2 0 5 0 0 0
2021/202226 0 0 0 0 3 0 0 0 4 5 4 10
2022/202364 4 8 0 7 11 12 2 4 12 0 2 2
2023/202466 2 12 5 2 6 12 2 0 0 3 1 21
2024/2025153 5 0 6 4 3 15 53 5 45 15 2 0
Totale 364